natgillin/translations-raw huggingface dataset:
Under det nuværende syvende rammeprogram er der for nyligt blevet tildelt støtte til adskillige projekter, der ser på sundhedsvirkningerne, såsom reproduktionsproblemer eller problemer med nervesystemets udvikling, af eksponering for kemikalier, herunder flammehæmmende midler Kataloger med de udvalgte projekter fra de første to forslagsindkaldelser under emnet miljø findes på: ftp://ftp.cordis.europa.eu/pub/fp7/environment/docs/catalogue_projects_2008.pdf og ftp://ftp.cordis.europa.eu/pub/fp7/environment/docs/catalogue-projects-fp7envnmp_en.pdf .
In the current Seventh Framework Programme (FP7), several projects have been recently selected for funding, looking at health impacts such as problems of reproduction or neurodevelopment, of exposure to chemicals including flame retardants Catalogues of selected projects from the first two calls for proposals under the theme Environment are available at: ftp://ftp.cordis.europa.eu/pub/fp7/environment/docs/catalogue_projects_2008.pdf and ftp://ftp.cordis.europa.eu/pub/fp7/environment/docs/catalogue-projects-fp7envnmp_en.pdf .
Derudover er Kommissionen i færd med at forhandle et nyt projekt (ENFIRO) med det formål at analysere livscyklussen for mulige erstatninger for polybromerede flammehæmmende midler.
In addition, the Commission is in the process of negotiating a new project (Enfiro) with the aim of analysing the life-cycle of potential substitutes to poly-brominated flame retardants.
De mulige stoffer vil blive undersøgt for miljømæssige og toksikologiske risici samt for muligheden for industriel gennemførelse, dvs. produktion af det flammehæmmende middel, brandsikkerhed og anvendelse af flammehæmmende midler i produkter (elektronikvarer, møbler, maling, skum osv.).
The candidate substances will be studied for environmental and toxicological risks, and for viability of industrial implementation, i.e. production of the flame retardants, fire safety and application of flame retardants into products (electronics, furniture, paints, foams, etc.).
Alle de oplysninger, der fremkommer under disse undersøgelser, vil blive anvendt til en komplet livscyklusvurdering.
All information developed under these tests will be used for a complete life cycle assessment.
Endelig fremmer undersøgelser til støtte for politikudviklingen, såsom den forestående revision af RoHS-direktivet, yderligere viden om den socioøkonomiske gennemførlighed og virkningerne af erstatninger for de forbudte stoffer i elektrisk og elektronisk udstyr.
Finally, studies initiated to support policy development, such as the forthcoming review of the RoHS Directive, further promote knowledge on socioeconomic feasibility and impacts of substitution of the prohibited substances in electric and electronic equipments.
SKRIFTLIG FORESPØRGSEL E-6259/08
WRITTEN QUESTION E-6259/08
Om: Fællesskabsbestemmelserne om koordinering af social sikring
Subject: Community rules on the coordination of social security
I henhold til forordningens artikel 73, er en person, der er omfattet af en medlemsstats lovgivning, berettiget til at modtage familieydelser for sine børn, som er bosiddende i en anden medlemsstat.
Under Article 73 of that regulation, a person who is subject to the legislation of a Member State is entitled to claim family benefits in respect of his or her children who are living in another Member State.
Finder samme regler anvendelse for Irlands vedkommende i forbindelse med tilskud til pasning af småbørn, som betales hvert kvartal til forældre til børn under fem som støtte til dækning af omkostninger ved børnepasning?
With regard to Ireland, does the same apply to Early Childcare Supplements which are paid quarterly to parents of children under five to help with childcare costs?
SKRIFTLIG FORESPØRGSEL E-6260/08
WRITTEN QUESTION E-6260/08
Om: Faglige sammenslutninger eller fagforeninger for freelancejournalister
Subject: Professional associations or unions for freelance journalists
Er der i den europæiske konkurrencelovgivning en bestemmelse, som kan forhindre freelancejournalister i at danne en faglig sammenslutning eller fagforening med henblik på forhandling af betalingssatser og generelle betingelser med deres arbejdsgivere?
Is there any provision in European competition law that would prevent freelance journalists from forming a professional association or union to negotiate pay rates and terms and conditions with their employers?
SKRIFTLIG FORESPØRGSEL E-6261/08
WRITTEN QUESTION E-6261/08
Om: Anerkendelse af fibromyalgi i EU, behovet for behandling af fibromyalgi i Europa og behovet for yderligere data om fibromyalgi
Subject: EU recognition for fibromyalgia, the need for treatments in Europe for fibromyalgia and the need for more data on fibromyalgia
Kommisær Vassiliou besvarede forespørgsel til skriftlig besvarelse E-4898/08 den 28. oktober 2008.
On 28 October 2008, Commissioner Vassiliou answered Written Question E‑4898/08.
I sit svar anførte hun følgende:
In her answer she stated that:
»Fibromyalgia and Chronic Fatigue Syndrome (CFS) have been, for years, controversial disorders.
‘Fibromyalgia and Chronic Fatigue Syndrome (CFS) have been, for years, controversial disorders.
There are a lot of experts within and outside the world of medicine who doubt that these disorders exist, while they are recognised by others.
There are a lot of experts within and outside the world of medicine who doubt that these disorders exist, while they are recognised by others.
This situation has given rise to major differences of opinion concerning the ability of fibromyalgia and Chronic Fatigue Syndrome (CFS) patients to work, and to their entitlement to social security benefits.
This situation has given rise to major differences of opinion concerning the ability of fibromyalgia and Chronic Fatigue Syndrome (CFS) patients to work, and to their entitlement to social security benefits.
However, the current version of the International Classification of Diseases (ICD-10) does now recognise Fibromyalgia (Code M79.7)« (Imidlertid anerkender den gældende udgave af diagnosesystemet International Classification of Diseases (ICD-10) nu fibromyalgi (Kode M79.7).
However, the current version of the International Classification of Diseases (ICD-10) does now recognise Fibromyalgia (Code M79.7).’
I lande, som har en veludviklet sundhedsinfrastruktur, kan denne sygdom blive diagnosticeret og behandlet, men det er ikke altid tilfældet i nye medlemsstater.
In countries with a developed health infrastructure this disease can be diagnosed and treated, whereas in the new Member States that is not always the case.
Mener Rådet, at det er nødvendigt at træffe foranstaltninger på EU-plan til gavn for de europæiske borgere for at undgå uoverensstemmelser mellem diagnoser og behandlinger i medlemsstaterne?
Does the Council think that there is a need for action at European level, in the interests of European citizens, in order to avoid the disparities in diagnoses and treatment which exist in all Member States?
Kan Rådet kommentere den manglende adgang til godkendte behandlinger af fibromyalgi i EU?
Can the Council comment on the lack of availability of approved treatments in the EU for fibromyalgia?
Millioner af mennesker, der lider af fibromyalgi i Europa, har ikke samme adgang til lægemidler til behandling af fibromyalgi som i USA.
Millions of people suffering from fibromyalgia across Europe do not have the same access to medicines to treat fibromyalgia as in the US.
Udvalget for Humanmedicinske Lægemidler (CHMP) traf i kølvandet på dets møde i oktober en negativ afgørelse vedrørende det første lægemiddel til behandling af fibromyalgi i Europa.
Following its October meeting, the Committee for Medicinal Products for Human Use (CHMP) took a negative decision regarding the first medicine for the treatment of fibromyalgia in Europe.
Patienter i Europa var skuffede over at høre, at der ikke var blevet tildelt en autorisation til at godkende et lægemiddel til behandling af fibromyalgi.
Patients across Europe were disappointed to hear that a licence to approve a drug for fibromyalgia had not been granted.
Dog forholder det sig i virkeligheden således, at patienter i Europa benytter sig af off label-anvendelse af lægemidler.
Yet the reality is that in Europe patients are taking medicines off-label.
Hvilken løsning kan Rådet se på dette særlige problem?
What solution does the Council see for this specific problem?
Der er behov for at indsamle EU-data med henblik på at sikre behandling af fibromyalgi.
In order to obtain a treatment for fibromyalgia, there is a need to collect EU data.
Kan Rådet hjælpe med at indsamle og modtage data samt bidrage til en samordning af national ekspertise på området?
Can the Council help collect and receive data and also help with the coordination of national expertise?
Rådet har endnu ikke drøftet det specifikke spørgsmål vedrørende diagnosticering og behandling af fibromyalgi, da hovedansvaret for sundhed og sundhedspleje i almindelighed og mulighederne for kommende EU-tiltag vedrørende fibromyalgi i særdeleshed ligger hos medlemsstaterne.
The Council has not so far discussed the specific issue of diagnosis and treatment of fibromyalgia given that the primary responsibility for health and healthcare in general, and the possibilities for future European action in the field of fibromyalgia in particular, remain with Member States.
Udvalget for Humanmedicinske Lægemidler (CHMP) er et videnskabeligt udvalg, der har ansvaret for den første vurdering af lægemidler, for hvilke der ansøges om markedsføringstilladelse for hele Fællesskabet i henhold til artikel 5, stk. 2, i forordning (EF) nr. 726/2004 EUT L 136 af 30.4.2004, s. 1. .
The Committee for Medicinal Products for Human Use (CHMP) is a scientific committee responsible for initial assessment of medicinal products for which a Community-wide marketing authorisation is sought in accordance with Article 5(2) of Regulation (EC) No 726/2004 OJ L 136/1, 30.4.2004. .
I sine vurderinger fastslår CHMP navnlig, om det pågældende produkt opfylder de nødvendige krav til kvalitet, sikkerhed og virkning (artikel 12 i forordning (EF) nr. 726/2004).
Assessments conducted by the CHMP determine in particular whether or not the products concerned meet the necessary quality, safety and efficacy requirements (Article 12 of Regulation (EC) No 726/2004).
Det tilkommer ikke Rådet at kommentere de afgørelser, som CHMP træffer som led i udførelsen af sine opgaver.
It is not for the Council to comment on decisions taken by the CHMP in exercise of its reponsibilities.
Rådet skal også gøre det ærede medlem opmærksom på Fællesskabets program for sundhed for 2008 og syvende rammeprogram for forskning, teknologisk udvikling og demonstration, der giver mulighed for at fremsætte projektforslag om neurodegenerative sygdomme, fibromyalgi og kronisk træthedssyndrom (CFS).
The Council would also draw the attention of the Honourable Member to the 2008 Community Health Programme and the 7th Framework Programme for research and technological development, which include possibilities for project proposals concerning neurodegenerative diseases, fibromyalgia and Chronic Fatigue Syndrome (CFS).
SKRIFTLIG FORESPØRGSEL E-6262/08
WRITTEN QUESTION E-6262/08
Kommissær Vassiliou besvarede forespørgsel til skriftlig besvarelse E-4898/08 den 28. oktober 2008.
On 28 October 2008, Commissioner Vassiliou answered Written Question E‑4898/08.
Kommissionen bedes tilkendegive sin holdning til fibromyalgi, ligesom WHO gjorde det i 1992.
Can the Commission state its position on fibromyalgia, as the WHO did in 1992?
Mener Kommissionen, at det er nødvendigt at træffe foranstaltninger på EU-plan til gavn for de europæiske borgere for at undgå uoverensstemmelser mellem diagnoser og behandlinger i medlemsstaterne?
Does the Commission think that there is a need for action at European level, in the interests of European citizens, in order to avoid the disparities in diagnoses and treatment which exist in all Member States?
Kan Kommissionen kommentere den manglende adgang til godkendte behandlinger af fibromyalgi i EU?
Can the Commission comment on the lack of availability of approved treatments in the EU for fibromyalgia?
Hvilken løsning kan Kommissionen se på dette særlige problem?
What solution does the Commission see for this specific problem?
Kan Kommissionen hjælpe med at indsamle og modtage data samt bidrage til en samordning af national ekspertise på området?
Can the Commission help collect and receive data and also help with the coordination of national expertise?
SKRIFTLIG FORESPØRGSEL E-6264/08
WRITTEN QUESTION E-6264/08
Om: EU's uretmæssige brug af anerkendelsen af Kosovos uafhængighed som et pressionsmiddel i Serbiens tiltrædelsesforhandlinger
Subject: EU's undue use of the recognition of Kosovo's independence as a means of pressure in Serbia's EU accession negotiations
Da Kosovo ensidigt erklærede sin uafhængighed, opfordrede EU kun Serbien til at afholde sig fra enhver voldelig reaktion mod denne beslutning, herunder anvendelsen af sanktioner og hindringer for den regionale integration af den nye selvbestemmende enhed.
When Kosovo unilaterally proclaimed its independence, the EU only asked Serbia to refrain from any violent reaction against that decision, including the recourse to sanctions or obstacles to the regional integration of the newly self-determined entity.
Der hersker en enstemmig fælles holdning om, at Serbien, til trods for normale følelser af national ydmygelse og skuffelse over anerkendelsen af Kosovo som en uafhængig stat af nogle EU-medlemmer, undgik enhver aggressiv politik.
It is a unanimously shared opinion that, despite normal feelings of national humiliation and the disappointment produced by the recognition of Kosovo as an independent state by some EU Members, Serbia avoided any aggressive policy.
Serbien anvendte ingen sanktioner, støttede ikke en økonomisk boykot af Kosovo og skabte ingen forhindringer for Kosovos deltagelse i det regionale samarbejde.
It did not apply sanctions, did not enhance an economic boycott against Kosovo and did not raise obstacles to the participation of Kosovo in regional cooperation.
Endvidere udvidede Serbien samarbejdet med ICTY og øgede indsatsen i forbindelse med landets europæiske integration og forberedelsen af det kommende EU-medlemskab.
Moreover, Serbia increased its cooperation with the ICTY and intensified the efforts dedicated to its European integration and its proper preparation for future EU membership.
Da Kosovos internationale selvbestemmelse ikke blev anerkendt af FN og dermed ikke opnåede fuld virkning i den internationale retsorden, var EU på den anden side ikke i stand til for alvor at styrke en række af dets beslutninger efter denne separatistiske handling.
On the other hand, since the international self-determination of Kosovo was not recognised by the UN and, thus, did not produce full effects in the international legal order, the EU was unable to enhance properly some of its decisions following that separatist act.
Det Europæiske Råd fandt det angiveligt derfor hensigtsmæssigt at insistere på, at Serbien skal have en aktiv rolle frem for blot at være ikkeobstruerende.
Therefore, allegedly, the European Council found it appropriate to insist that Serbia shifts from a mere non-obstructionist attitude to an active role.
Dette indebærer støtte til fremme af konsekvenserne af en beslutning, som under dets forfatning ikke er acceptabel (blandt andet gennemførelsen af EULEX).
This implies support for the enhancement of the consequences of a decision which, under its Constitution, is not admissible (deployment of EULEX inter alia ).
I denne forbindelse henledte repræsentanter for Det Europæiske Råd de serbiske myndigheders opmærksomhed på det faktum, at deres manglende overholdelse af sådanne nye krav ville udelukke landet fra det europæiske perspektiv.
To this end, representatives of the European Council drew the attention of the Serbian authorities to the fact that their lack of compliance with such new exigencies would exclude the European perspective for the country.
Det lader således til, at EU-tiltrædelse er blevet et redskab til ulovlig pression for at påtvinge gennemførelsen af ensidige beslutninger, der muligvis reelt set er berettigede, men som blev vedtaget ved en procedure og en fremgangsmåde, som gør dem vanskelige for en suveræn stat, herunder Serbien, at acceptere og håndhæve.
Thus, it seems that EU accession has become a tool for unlawful pressure meant to impose the implementation of unilateral decisions which, although maybe justified in substance, were adopted through a procedure and in a format making them hardly acceptable to and enforceable by a sovereign state, namely Serbia.
Rådet bedes på baggrund af ovenstående oplyse følgende: 1.
Against this background, can the Council answer the following questions: 1.
Er de oplysninger, ifølge hvilke EU bruger Serbiens mulighed for at blive medlem af EU som et pressionsmiddel for at forpligte en suveræn europæisk stat til at acceptere konsekvenserne af dens deling, præcise? 2.
Is the information accurate according to which the EU is using the prospect of membership for Serbia as a means of pressure to oblige a sovereign European state to accept the consequences of its partition? 2.
Set i lyset af at EU's eneste mål i forbindelse med Serbiens medlemskab er at sikre Serbiens accept af Kosovos løsrivelse, er Serbiens tiltrædelse til EU da udelukkende en sag af interesse for dette land? 3.
Is Serbia's accession to the EU a matter of interest only to that country, the acceptance by Serbia of the Kosovo secession being the sole objective of the EU related to Serbia's membership? 3.
Kan man forvente loyalitet af et fremtidigt medlem, som opnåede sin tiltrædelse til EU ved at acceptere en ensidig udenlandsk beslutning, der, selvom den måtte være berettiget, ikke blev fremmet gennem positiv motivation, men derimod blev pålagt gennem trusler og pression? 4.
Could one expect loyalty from a future Member which obtained its accession to the EU by accepting a unilateral foreign decision which, even if justified, was not enhanced through positive motivation, but imposed through threats and pressure? 4.
Er Rådet parat til at overveje en måde, hvorpå Kosovos status kan inddrages i den internationale retsorden, og Serbiens status kan inddrages i EU's politiske orden?
Is the Council ready to consider a way of bringing the status of Kosovo into the international legal order and the status of Serbia into the EU political order?
Rådet har ved flere lejligheder gentaget, at alle landene i det vestlige Balkan, herunder Serbien, har et europæisk perspektiv.
The Council has repeatedly stated that all countries of the western Balkans, including Serbia, have a European perspective.
Rådet henviser til sine konklusioner herom og især konklusionerne fra Det Europæiske Råds møde i Thessaloniki den 19.-20. juni 2003, hvori Det Europæiske Råd gentog, »at det er fast besluttet på fuldt ud og effektivt at støtte det europæiske perspektiv for landene i det vestlige Balkan, der vil blive en integrerende del af EU, når de opfylder de opstillede kriterier«.
The Council recalls its conclusions to that effect and in particular the conclusions of the Thessaloniki European Council of 19 and 20 June 2003, which state ‘the European Council reiterated its determination to fully and effectively support the European perspective of the western Balkans countries, which will become an integral part of the EU, once they meet the established criteria’.
Dette tilsagn blev gentaget på Det Europæiske Råds møde den 19.-20. juni 2008.
This commitment was reiterated at the European Council of 19 and 20 June 2008.
Det hedder i konklusionerne, at »Det Europæiske Råd bekræfter på ny sin fulde støtte til det europæiske perspektiv for landene på Vestbalkan som fastlagt i Thessalonikidagsordenen og Salzburgerklæringen.
The conclusions state that ‘the European Council reaffirms its full support for the European perspective of the western Balkans as set out in the Thessaloniki Agenda and the Salzburg Declaration.
Under henvisning til sine konklusioner fra december 2006 understreger Det Europæiske Råd, at de resterende potentielle kandidatlande på Vestbalkan på baggrund af deres egen indsats burde få kandidatstatus med EU-medlemskab som det endelige mål, hvis de gør solide fremskridt med de økonomiske og politiske reformer og opfylder de nødvendige betingelser og krav«.
Recalling its conclusions of December 2006, the European Council stresses that by making solid progress in economic and political reform and by fulfilling the necessary conditions and requirements, the remaining potential candidates in the western Balkans should achieve candidate status, according to their own merits, with EU membership as ultimate goal’.
Med hensyn til Serbien blev det på samme møde i Det Europæiske Råd understreget, at Serbien kan »sætte mere fart i sine fremskridt hen imod EU, herunder opnåelse af kandidatstatus, så snart alle de nødvendige betingelser er opfyldt, jf. AGEX-Rådets konklusioner af 29. april 2008«.
On Serbia, the same European Council stressed that ‘Serbia can accelerate its progress towards the EU, including candidate status, as soon as all necessary conditions are met in accordance with the Council conclusions of 29 April 2008’.
Der mindes om, at Rådet i februar 2008 vedtog følgende konklusioner: »Rådet noterer sig, at medlemsstaterne i overensstemmelse med national praksis og folkeretten vil tage stilling til deres forbindelser med Kosovo.
It is recalled that in February 2008, the Council adopted the following conclusions: ‘The Council notes that Member States will decide, in accordance with national practice and international law, on their relations with Kosovo.
Rådet gentager EU's tilslutning til principperne i FN-pagten og Helsingforsslutakten, blandt andet suverænitetsprincippet og princippet om territorial integritet og alle FN's Sikkerhedsråds resolutioner.
The Council reiterates the EU's adherence to the principles of the UN Charter and the Helsinki Final Act, inter alia the principles of sovereignty and territorial integrity and all UN Security Council resolutions.
Som Det Europæiske Råd erklærede i december 2007: »EU er rede til at støtte den økonomiske og politiske udvikling af Kosovo gennem et klart europæisk perspektiv i overensstemmelse med regionens europæiske perspektiv.«.
As stated in December 2007 by the European Council: ‘The EU will be ready to assist economic and political development through a clear European perspective, in line with the European perspective of the region’.
SKRIFTLIG FORESPØRGSEL E-6265/08
WRITTEN QUESTION E-6265/08
Om: Manglende yderligere undersøgelser af sødemidlet steviosid
Subject: Failure to perform additional research into the sweetener stevioside
Den 6. juli 2007 udtalte Kommissionen i et svar på forespørgsel E-2950/07 , at den havde bedt Den Europæiske Fødevaresikkerhedsautoritet (EFSA) om yderligere undersøgelser af, hvor sikker steviosid er.
On 6 July 2008 the Commission stated in reply to Written Question E‑2950/07 that it had asked the European Food Safety Authority (EFSA) to perform additional research into the safety of stevioside.
Til dato har EFSA ingen skridt taget i den retning.
To this day, EFSA has not taken any steps in that direction.
Der er gået næsten halvandet år.
In the meantime, nearly a year and a half has passed.
Der er allerede 164 mio. mennesker i Amerika, Australien og New Zealand, der hver dag bruger steviosid uden skadelige virkninger.
Every day, 164 million people in America, Australia and New Zealand are already consuming stevioside without any harm befalling them.
Ved Kommissionen i givet fald, hvorfor EFSA intet foretager sig desangående?
If so, does the Commission know why EFSA is not making any progress on this?
Hvorfor holder Kommissionen så hårdnakket tilladelsen tilbage i EU, når nu videnskaben entydigt garanterer, at steviosid er sikkert?
Why is the Commission opposing the approval of stevioside in the European Union so strenuously, as scientists unanimously guarantee that stevioside is safe? —
Kan Kommissionen sige, om sukkerlobbyen forsøger at forhindre, at et naturligt planteekstrakt kan mindske store sundhedsproblemer og -omkostninger?
Can the Commission say whether the sugar lobby is trying to prevent a natural vegetable extract from reducing major health problems and costs?